Editorial: Microorganisms and Their Derivatives for Cancer Therapy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Liu M, OConnor R, Trefely S, Graham K, Snyder N, Beatty G
. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal. Nat Immunol. 2019; 20(3):265-275.
PMC: 6380920.
DOI: 10.1038/s41590-018-0292-y.
View
2.
Liu Y, Feng J, Pan H, Zhang X, Zhang Y
. Genetically engineered bacterium: Principles, practices, and prospects. Front Microbiol. 2022; 13:997587.
PMC: 9606703.
DOI: 10.3389/fmicb.2022.997587.
View
3.
Dobosz P, Dzieciatkowski T
. The Intriguing History of Cancer Immunotherapy. Front Immunol. 2020; 10:2965.
PMC: 6928196.
DOI: 10.3389/fimmu.2019.02965.
View
4.
Kurtz C, Millet Y, Puurunen M, Perreault M, Charbonneau M, Isabella V
. An engineered Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med. 2019; 11(475).
DOI: 10.1126/scitranslmed.aau7975.
View
5.
Ma Y, Jiao Y, Yu Y, Jiang N, Hua Y, Zhang X
. A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response. Viruses. 2018; 10(1).
PMC: 5795451.
DOI: 10.3390/v10010038.
View